Is cervical cerclage indicated in pregnant patients with uterine fibroids?

Cervical Cerclage in Fibroid Pregnancies

Cervical cerclage is NOT routinely indicated in pregnant patients with uterine fibroids unless they develop a short cervix (<25 mm) or cervical dilation, at which point management follows standard short cervix protocols rather than fibroid-specific protocols. 1

Key Management Principles

The presence of uterine fibroids alone does not constitute an indication for prophylactic cerclage. Management should be based on cervical assessment rather than fibroid presence:

When Cerclage is NOT Recommended

• In patients without prior spontaneous preterm birth who have a sonographic short cervix (10-25 mm), cerclage placement is NOT recommended in the absence of cervical dilation 1
• The Society for Maternal-Fetal Medicine explicitly recommends against cerclage in this population based on lack of demonstrated benefit in reducing preterm birth 1
• This recommendation applies regardless of fibroid presence, as fibroids themselves do not change the cerclage indication criteria 1

When Cerclage MAY Be Considered

Cerclage placement can be considered only in specific circumstances:

• Cervical length <10 mm: Even without cervical dilation, cerclage may be discussed based on shared decision-making, as subgroup analysis showed potential benefit (39.5% vs 58.0% preterm birth rate; RR 0.68) 1
• Presence of cervical dilation: When cervical shortening progresses to dilation, examination-indicated cerclage becomes appropriate 1
• Important caveat: 30-70% of patients with very short cervix (<11-15 mm) have cervical dilation on examination, so physical exam should be performed when severe shortening is detected 1

Recommended Management Algorithm for Fibroid Pregnancies

Step 1: Cervical Length Surveillance

• Perform transvaginal ultrasound cervical length assessment in midtrimester (18-24 weeks) 1
• Use standardized measurement techniques per Perinatal Quality Foundation or Fetal Medicine Foundation protocols 1
• Diagnose short cervix at threshold of ≤25 mm 1

Step 2: Treatment Based on Cervical Length

For cervical length ≤20 mm:

• Prescribe vaginal progesterone (GRADE 1A recommendation) 1
• This is the first-line intervention, NOT cerclage 1

For cervical length 21-25 mm:

• Consider vaginal progesterone based on shared decision-making 1

For cervical length <10 mm:

• Perform cervical examination to assess for dilation 1
• If no dilation: Discuss potential cerclage placement with patient, though evidence is limited 1
• If dilation present: Examination-indicated cerclage becomes appropriate 1

Step 3: Avoid Ineffective Interventions

• Do NOT use 17-alpha hydroxyprogesterone caproate (withdrawn by FDA for lack of efficacy) 1
• Do NOT place cervical pessary (GRADE 1B recommendation against) 1

Special Consideration: Fibroid-Specific Data

One retrospective study of 120 pregnant women with large fibroids (≥8 cm) showed that combining Arabin pessary or cerclage with micronized progesterone reduced preterm delivery rates by 2.2-fold versus progesterone alone 2. However, this contradicts high-quality guideline recommendations against routine cerclage and pessary use 1.

Critical limitation: This single retrospective study 2 cannot override the SMFM's 2024 GRADE 1B recommendation against cerclage in patients without prior preterm birth who have short cervix without dilation 1. The guideline evidence is based on meta-analysis of 5 randomized trials showing no benefit of cerclage in this population 1.

Common Pitfalls to Avoid

• Do not place prophylactic cerclage based solely on fibroid size or number 1
• Do not assume fibroids change standard short cervix management protocols 1
• Do not use cerclage as first-line therapy when vaginal progesterone is indicated 1
• Do not skip cervical examination when cervical length is <11-15 mm, as many patients have occult dilation requiring different management 1